veeva.com/eu Dicerna Harmonizes Quality Management with Veeva Vault Quality Suite End-to-end digital platform increases efficiency by 50% and reduces paperwork by 90% 1 Dicerna Pharmaceuticals, Inc., a leading developer of investigational ribonucleic acid interference (RNAi), creates medicines that silence or turn off the genes that cause disease. With a vision to maximize the impact of RNAi on medicine and deliver lifesaving therapeutic medicines, the company needed to modernize its vast and fragmented quality system landscape that was difficult to use and costly to maintain. “We needed to transform our paper-based quality systems into one intelligent, data-driven, end-to-end digital platform to harmonize quality across all sites and operational areas while improving user ex

Join for free to read